NCT05924711

Brief Summary

Scientific evidence regarding the influence of peri-implantitis on Schneider's membrane thickening is scarce and limited. Similarly, to date, there is no literature documenting the resolution of implant-associated maxillary sinusitis with peri-implantitis after treatment of peri-implantitis or removal of the implant. Therefore, the aim of this case-control study is to investigate the association between peri-implantitis and maxillary sinusitis. On the other hand, the changes that occur at the level of the maxillary sinus membrane after treatment of peri-implantitis or after implant explantation will be evaluated.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 6, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

June 6, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

June 29, 2023

Completed
6 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 5, 2023

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2023

Completed
Last Updated

June 29, 2023

Status Verified

June 1, 2023

Enrollment Period

29 days

First QC Date

June 6, 2023

Last Update Submit

June 26, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sinus membrane thickening changes after peri-implantitis treatment

    Sagital and coronal linear measurements of membrane thickening

    6 months

Secondary Outcomes (2)

  • Severity of peri-implantitis in implants with maxillary sinusitis

    1 month

  • Volume dimensional changes of the sinus membrane

    1 month

Study Arms (2)

Case group

The case group will consist of 20 patients who will have implants diagnosed with peri-implantitis, according to the 2017 World Workshop Classification case definition.

Other: Retrospective analysis of demographic and radiographic data previously obtained from the patient.

Control group

The control group will include 20 subjects who will have implants with peri-implant health according to the 2017 World Workshop Classification case definition.

Other: Retrospective analysis of demographic and radiographic data previously obtained from the patient.

Interventions

The patient's demographic data obtained previously by anamnesis and clinical examination will be retrospectively analyzsed. On the other hand, a radiographic evaluation including analysis of the implants, adjacent teeth and maxillary sinuses/sinus membranes shall be performed using computer software.

Case groupControl group

Eligibility Criteria

Age18 Years - 80 Years
Sexall(Gender-based eligibility)
Gender Eligibility DetailsMen and women between 18-80 years of age
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients included in the study signed the corresponding informed consent forms for each of the treatments received, as well as for the use of their demographic and radiographic data for scientific purposes. The subjects recruited will be edentulous (partial/total) patients who previously had implants placed in the posterior region of the maxilla for oral rehabilitation. The case group will consist of 20 patients who will have implants diagnosed with peri-implantitis while in the control group the 20 subjects included will have implants with peri-implant health.

You may qualify if:

  • Men and women between 18-80 years of age
  • Patients with implants in the posterior sector of the upper jaw
  • Dental implant carriers with a follow-up of more than 5 years
  • Patients who have undergone a CT scan for the evaluation of these implants or for other reasons

You may not qualify if:

  • Patients with uncontrolled systemic disease
  • Pregnant or lactating patients
  • Heavy smokers (HS)
  • Patients with uncontrolled or active periodontal disease in need of periodontal treatment
  • Patients with zygomatic or pterygoid implants
  • Patients taking medications known to modify bone metabolism or who have degenerative bone disease (hyperparathyroidism, osteoporosis), vitamin D, patients who have taken antibiotics, NSAIDs or corticosteroids for more than two weeks in the last 3 months prior to the examination.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Universitat Internacional de Catalunya (UIC)

Sant Cugat del Vallès, Barcelona, 08195, Spain

NOT YET RECRUITING

Ramon Pons

Barcelona, 08017, Spain

RECRUITING

MeSH Terms

Conditions

Peri-ImplantitisSinusitisBronchiolitis Obliterans Syndrome

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesRespiratory Tract InfectionsInfectionsParanasal Sinus DiseasesNose DiseasesRespiratory Tract DiseasesOtorhinolaryngologic DiseasesOrganizing PneumoniaBronchiolitis ObliteransBronchiolitisBronchitisBronchial DiseasesLung Diseases, ObstructiveLung DiseasesGraft vs Host DiseaseImmune System Diseases

Study Officials

  • Jose Nart, PhD

    UIC

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator, Clinical Professor

Study Record Dates

First Submitted

June 6, 2023

First Posted

June 29, 2023

Study Start

June 6, 2023

Primary Completion

July 5, 2023

Study Completion

July 15, 2023

Last Updated

June 29, 2023

Record last verified: 2023-06

Data Sharing

IPD Sharing
Will not share

Data collected from patients may only be processed by the research team of this study and will not be shared with other researchers.

Locations